Objective To explore the features of molecular epidemiology of deafness predisposing genes and to provide a basis for optimizing the strategy for pre-deaf through universal newborn genetic screening. Methods A total of 1 902 newborns were taken blood spot at heel in 3~5 days and accepted deafness predisposing genes screening.All samples performed the polymerase chain reaction (PCR)for screening GJB2 and the mitochondrial 12SrRNA as well as SLC26A4 gene mutations.Eight mutations of three genes(GJB2 35delG, 176-191del 16, 235delC and 299-300delAT, SLC26A4 IVS7-2A>G and 2168A>G , 12S rRNA 1494C >T and 1555A >G)were detected by matrix assister laser desorption/ionization time-of-flight mass spectrometry ( MALDI-TOF-MS ).The features of molecular epidemiology of deafness predisposing genes mutations in newborns were studied. Results The deafness predisposing genes screening showed there were 50 carriers in the 1 902 infants.The overall carrier frequency of five mutations of three genes was 2.63%, with 2.90% in males and 2.35% in females.3.51% in Chancheng district, 3.31% in Nanhai district and 3.10% in Shunde district.In different maternal age groups, the carrier frequency was 2.48%, 2.72% and 2.94% respectively.No infant was GJB2 35delG, 176-191del or 12S rRNA 1494C>T carrier, while all carriers of deafness predisposing genes passed the hearing screening. Conclusions The features of molecular epidemiology of deafness predisposing genes in Foshan revealed that there was no apparent difference in gender ratio, regional distribution and maternal age.Hearing concurrent genetic screening can find neonates with late-onset hearing impairment promptly and provide prognostic information for early treatment, which is significant for the optimization of the strategy for pre-deaf.
Key words
deafness /
gene /
molecular epidemiology /
newborn
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 第二次残疾人抽样调查办公室.全国第二次残疾人抽样调查主要数据手册[M].北京:华夏出版社, 2007:2-38.
[2] 韩明昱, 戴朴.我国耳聋基因诊断的临床应用进展[J].北京医学, 2011, 33(5):419-421.
[3] 王秋菊.新生儿聋病基因筛查实施方案与策略研究[J].中华耳鼻咽喉头颈外科杂志, 2007, 42(11):809-813.
[4] WHO.Report of the first informal consultation on future program developments for the prevention of deafness and hearing impairment[R].World Health Organization, Geneva, 1997, 23-24.
[5] 郭玉芬, 徐百成, 韩东一, 等.中国西北地区线粒体DNA12SrRNA A1555G和GJB2 基因突变[J].中国耳鼻咽喉头颈外科杂志, 2006, 13(10):666-669.
[6] 管敏鑫, 赵立东.与氨基糖甙类抗生素耳毒性相关的线粒体12SrRNA 突变的流行病学特征[J].中华耳科学杂志, 2006, 4(2):98-105.
[7] 郑文波, 罗建红, 郦云, 等.中国人语前非综合征性耳聋患者GJB2 基因的突变分析[J].中华儿科杂志, 2000, 38(10):610-613.
[8] 赵亚丽, 李庆忠, 翟所强, 等.国人前庭水管扩大患者SLC26A4 基因的特异性突变[J].听力学及言语疾病杂志, 2006, 14(2):93-96.
[9] 张东红, 邱海涛, 马秀岚, 等.新生儿聋病基因GJB2、SLC26A4、线粒体12S rRNA的分子流行病学研究[J].中国医科大学学报, 2010, 39(8):649-651.
[10] 李琦, 戴朴, 黄德亮, 等.SLC26A4基因IVS7-2A>G突变在中国不同地区和民族重度感音性聋患者中分布频率的观察[J].中华耳鼻咽喉头颈外科杂志, 2007, 42(12):893-897.
[11] 戴朴, 于飞, 康东洋, 等.线粒体DNA1555位点和GJB2基因及SLC26A4基因的诊断方法及临床应用[J].中华耳鼻咽喉头颈外科杂志, 2005, 40(10):769-773.